4
Changes in Ownership
BIOGEN INC. Filed Acc 0001127602-23-012691
Head of Development sold 91 shares at $277.11 ($25,217)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Singhal Priya Head of Development | 2023-04-04 | Sale 10b5-1 | −91 | $277.11 | $25,217 | 2,843.09 | D: show line 1 in the form |
| Open-market sales · 91 sh · avg $277.11 · $25,217 | |||||||
Loading xslF345X04/form4.xml…